Patient Case: Stage III MMRp/MSS Endometrial Cancer
Dr.Benoit You
Medical Oncologist
Lyon Unversity Hospital, France
Patients with Stage IlI and MMRp Endometrial Cancer
Prof. Dr. Klaus Pietzner
Concultant
Charite- University Medicine of Berlin, Germany
Dr. John K.Chan
Director, Gynecologic Oncology
California Pacific Medical
center, San Francisco, USA
Prof.DR. Beynhan Ataseven
Director, Department of Gynecology and Obstetrics
University of Bielefeld/Klinikum Lippe, Germany
Dr.Benoit You
Medical Oncologist
Lyon Unversity Hospital, France
Evaluating Endpoints in Oncology
Prof. Dr. Klaus Pietzner
Concultant
Charite- University Medicine of Berlin, Germany
Dr. John K.Chan
Director, Gynecologic Oncology
California Pacific Medical
center, San Francisco, USA
Prof.DR. Beynhan Ataseven
Director, Department of Gynecology and Obstetrics
University of Bielefeld/Klinikum Lippe, Germany
Dr.Benoit You
Medical Oncologist
Lyon Unversity Hospital, France
RUBY Part 1 - All Comers Data
Prof. Dr. Klaus Pietzner
Concultant
Charite- University Medicine of Berlin, Germany
Dr. John K.Chan
Director, Gynecologic Oncology
California Pacific Medical
center, San Francisco, USA
Dr.Benoit You
Medical Oncologist
Lyon Unversity Hospital, France
Highlights of the RUBY Part 1 Trial Design
Prof. Dr. Klaus Pietzner
Concultant
Charite- University Medicine of Berlin, Germany
Dr. John K.Chan
Director, Gynecologic Oncology
California Pacific Medical
center, San Francisco, USA
Prof.DR. Beynhan Ataseven
Director, Department of Gynecology and
Obstetrics
University of Bielefeld/Klinikum Lippe, Germany
Stage III pMMR/MSS endometrial cancer
Dr.Benoit You
Medical Oncologist Lyon Unversity Hospital, France
Har du spørsmål om JEMPERLI for dine pasienter? Kontakt oss
Jemperli trademark is a registered trademark of the GSK group of companies.
© 2025 GSK group of companies or its licensor.